ARTIVION, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ARTIVION, INC. (AORT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$4.64 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-10-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-10-31
- ARTIVION, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$1.08M.
- ARTIVION, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$2.31M.
- ARTIVION, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$1.25M.
- ARTIVION, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$2.75M.
- ARTIVION, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$73.85M.
- ARTIVION, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$4.49M.
- ARTIVION, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$5.35M, a 149.21% decline from fiscal 2013.
- ARTIVION, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was $10.88M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$3.39M derived: sum of 2 quarters · filed 2017-10-31 | -$4.64M 10-Q · filed 2017-10-31 | -$7.39M derived: sum of 4 quarters · filed 2017-10-31 |
| 2017-06-30 | -$2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | -$3.56M 10-Q · filed 2017-07-25 | -$6.31M derived: sum of 3 quarters · filed 2017-07-25 | -$8.25M derived: sum of 4 quarters · filed 2017-10-31 |
| 2017-03-31 | -$1.25M 10-Q · filed 2017-04-27 | -$3.99M derived: sum of 2 quarters · filed 2017-04-27 | -$5.94M derived: sum of 3 quarters · filed 2017-10-31 | -$7.95M derived: sum of 4 quarters · filed 2017-10-31 |
| 2016-12-31 | -$2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$4.69M derived: sum of 2 quarters · filed 2017-10-31 | -$6.70M derived: sum of 3 quarters · filed 2017-10-31 | -$73.85M 10-K · filed 2017-02-16 |
| 2016-09-30 | -$1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$3.95M derived: sum of 2 quarters · filed 2017-10-31 | -$71.11M 10-Q · filed 2017-10-31 | -$72.79M derived: sum of 4 quarters · filed 2017-10-31 |
| 2016-06-30 | -$2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | -$69.16M 10-Q · filed 2017-07-25 | -$70.84M derived: sum of 3 quarters · filed 2017-07-25 | -$71.86M derived: sum of 4 quarters · filed 2017-07-25 |
| 2016-03-31 | -$67.16M 10-Q · filed 2017-04-27 | -$68.84M derived: sum of 2 quarters · filed 2017-04-27 | -$69.85M derived: sum of 3 quarters · filed 2017-04-27 | -$70.09M derived: sum of 4 quarters · filed 2017-04-27 |
| 2015-12-31 | -$1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$2.70M derived: sum of 2 quarters · filed 2017-02-16 | -$2.94M derived: sum of 3 quarters · filed 2017-02-16 | -$4.49M 10-K · filed 2017-02-16 |
| 2015-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | -$1.25M derived: sum of 2 quarters · filed 2016-10-27 | -$2.80M 10-Q · filed 2016-10-27 | -$3.35M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-06-30 | -$238.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-26 | -$1.79M 10-Q · filed 2016-07-26 | -$2.33M derived: sum of 3 quarters · filed 2017-02-16 | -$3.35M derived: sum of 4 quarters · filed 2017-02-16 |
| 2015-03-31 | -$1.55M 10-Q · filed 2016-04-29 | -$2.10M derived: sum of 2 quarters · filed 2017-02-16 | -$3.11M derived: sum of 3 quarters · filed 2017-02-16 | -$5.22M derived: sum of 4 quarters · filed 2017-02-16 |
| 2014-12-31 | -$546.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | -$1.56M derived: sum of 2 quarters · filed 2017-02-16 | -$3.67M derived: sum of 3 quarters · filed 2017-02-16 | -$5.35M 10-K · filed 2017-02-16 |
| 2014-09-30 | -$1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | -$3.13M derived: sum of 2 quarters · filed 2015-10-27 | -$4.81M 10-Q · filed 2015-10-27 | $9.47M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-06-30 | -$2.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-28 | -$3.79M 10-Q · filed 2015-07-28 | $10.48M derived: sum of 3 quarters · filed 2016-02-16 | $9.46M derived: sum of 4 quarters · filed 2016-02-16 |
| 2014-03-31 | -$1.68M 10-Q · filed 2015-04-29 | $12.60M derived: sum of 2 quarters · filed 2016-02-16 | $11.57M derived: sum of 3 quarters · filed 2016-02-16 | $10.27M derived: sum of 4 quarters · filed 2016-02-16 |
| 2013-12-31 | $14.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | $13.25M derived: sum of 2 quarters · filed 2016-02-16 | $11.95M derived: sum of 3 quarters · filed 2016-02-16 | $10.88M 10-K · filed 2016-02-16 |
| 2013-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28 | -$2.33M derived: sum of 2 quarters · filed 2014-10-28 | -$3.40M 10-Q · filed 2014-10-28 | |
| 2013-06-30 | -$1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | -$2.37M 10-Q · filed 2014-07-24 | ||
| 2013-03-31 | -$1.07M 10-Q · filed 2014-04-30 | |||
| 2012-12-31 | -$22.92M 10-K · filed 2015-02-17 | |||
| 2011-12-31 | -$27.72M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |